PharmacyCodes



Serostim (Serono SA) en es it fr

Serostim (Serono SA) Brand names, Serostim (Serono SA) Analogs

Serostim (Serono SA) Brand Names Mixture

  • No information avaliable

Serostim (Serono SA) Chemical_Formula

C990H1532N262O300S7

Serostim (Serono SA) RX_link

http://www.rxlist.com/cgi/generic3/nutropin.htm

Serostim (Serono SA) fda sheet

Serostim (Serono SA) msds (material safety sheet)

Serostim (Serono SA) Synthesis Reference

No information avaliable

Serostim (Serono SA) Molecular Weight

22129.0

Serostim (Serono SA) Melting Point

76 oC at pH 3.5 (Gomez-Orellana, I. et al., Protein Sci. 7:1352-1358 (1998).

Serostim (Serono SA) H2O Solubility

No information avaliable

Serostim (Serono SA) State

Liquid

Serostim (Serono SA) LogP

-0.411

Serostim (Serono SA) Dosage Forms

Solution (Subcutaneous Injection); Powder for solution

Serostim (Serono SA) Indication

For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss

Serostim (Serono SA) Pharmacology

Used in the treatment of dwarfism and growth failure, growth hormone (hGH) stimulates skeletal growth in pediatric patients with growth failure due to a lack of adequate secretion of endogenous GH. Skeletal growth is accomplished at the epiphyseal plates at the ends of a growing bone. Growth and metabolism of epiphyseal plate cells are directly stimulated by GH and one of its mediators, IGF-I (insulin-like growth factor).

Serostim (Serono SA) Absorption

No information avaliable

Serostim (Serono SA) side effects and Toxicity

No information avaliable

Serostim (Serono SA) Patient Information

BIOD00086.html

Serostim (Serono SA) Organisms Affected

Humans and other mammals